New hope for DVT patients: common arthritis drug may prevent lasting vein damage
Disease control
Not yet recruiting
This study tests whether adding colchicine, an anti-inflammatory medicine, to standard blood thinners can reduce the risk of long-term vein damage (post-thrombotic syndrome) in people with a first-time deep vein clot in the leg. About 940 adults will receive either colchicine or …
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated May 22, 2026 14:03 UTC